Dipexium Pharmaceuticals, Inc. Report issue

For profit Phase 3
Founded: White Plains NY United States (2010)
Status: Acquired by PLx Pharma (2016)

Organization Overview

First Clinical Trial
2014
NCT01594762
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

pexiganan acetate (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1